[HTML][HTML] Counting the burden: atopic dermatitis and health-related quality of life

ALI Faraz, V Jui, AY Finlay - Acta dermato-venereologica, 2020 - ncbi.nlm.nih.gov
Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The
burden of atopic dermatitis on children and adults is extensive and there is also significant …

Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online …

J Vyas, N Muirhead, R Singh, R Ephgrave, AY Finlay - BMJ open, 2022 - bmjopen.bmj.com
Objectives The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their …

HTLV‐1‐associated infective dermatitis: updates on the pathogenesis

NK McGill, J Vyas, T Shimauchi… - Experimental …, 2012 - Wiley Online Library
HTLV ‐1‐associated infective dermatitis ( HAID ) is the main paediatric manifestation of
human T‐cell lymphotropic virus type 1 ( HTLV ‐1). It is characterised by a chronic exudative …

[HTML][HTML] Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): major impact on lives of both patients and family members

E Brittain, N Muirhead, AY Finlay, J Vyas - Medicina, 2021 - mdpi.com
Background and objectives: To explore the impacts that Myalgic Encephalomyelitis/Chronic
Fatigue Syndrome (ME/CFS) has on the patient and their family members using the …

[HTML][HTML] Traction alopecia: A neglected entity in 2017

CO Akingbola, J Vyas - Indian journal of dermatology, venereology and …, 2017 - ijdvl.com
Traction alopecia was first described in 1904 but is still a cause of scarring hair loss in
young women worldwide. It is unique in being initially a reversible then an irreversible (scarring) …

A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries

J Vyas, JR Johns, FM Ali, RK Singh… - British Journal of …, 2024 - academic.oup.com
Background Over 29 years of clinical application, the Dermatology Life Quality Index (DLQI)
has remained the most used patient-reported outcome (PRO) in dermatology due to its …

Long-term use of a 4% sodium cromoglicate cutaneous emulsion in the treatment of moderate to severe atopic dermatitis in children

…, R Clifford, A Thomas, R Gamanya, J Vyas… - Journal of …, 2015 - Taylor & Francis
Introduction: Sodium cromoglicate (SCG), a chromone with anti-inflammatory, anti-itch and
anti-allergic properties. We report a long-term study of a 4% aqueous solution of SCG in …

P82 Validation of the dermatology life quality index (DLQI): a systematic review of the literature

J Johns, J Vyas, F Ali, J Ingram, S Salek… - British Journal of …, 2023 - academic.oup.com
The Dermatology Life Quality Index (DLQI) was first published in 1994, and, since that time,
it has become the most widely used patient-reported outcome measure worldwide in …

Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.

A Altayeb, A Cordaro, J Caesar, J Vyas, J Ingram - 2020 - cabidigitallibrary.org
This paper describes two cases of laboratory-confirmed COVID-19 infection presenting with
cutaneous manifestations prior to the onset of respiratory symptoms. Case 1: A 29-year-old …

[PDF][PDF] The impact of interventions on quality of life in psoriasis and the concept of multiple minimal clinically important difference (MCID): a systematic review

FM Ali, A Cueva, J Vyas, AA Atwan… - Journal of …, 2016 - researchgate.net
Interventions often result in statistically significant quality of life (QoL) improvement, but may
not reach the threshold of clinical importance. The minimal clinically important difference (…